Cargando…

Novel PPAR Pan Agonist, ZBH Ameliorates Hyperlipidemia and Insulin Resistance in High Fat Diet Induced Hyperlipidemic Hamster

Effective and safe pharmacological interventions for hyperlipidemia remains badly needed. By incorporating the key pharmacophore of fibrates into the natural scaffold of resveratrol, a novel structural compound ZBH was constructed. In present study, we found ZBH reserved approximately one third of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Wei, Fan, Shiyong, Xie, Xinni, Xue, Nina, Jin, Xueyuan, Wang, Lili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997506/ https://www.ncbi.nlm.nih.gov/pubmed/24759758 http://dx.doi.org/10.1371/journal.pone.0096056

Ejemplares similares

Regulation of microRNAs in high-fat diet induced hyperlipidemic hamsters
por: Barbalata, Teodora, et al.
Publicado: (2020)

Effect of Berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamsters
por: Li, Xiao-Yang, et al.
Publicado: (2015)

The PPAR pan-agonist bezafibrate ameliorates cardiomyopathy in a mouse model of Barth syndrome
por: Huang, Yan, et al.
Publicado: (2017)

Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
por: Zhang, Li-Song, et al.
Publicado: (2012)

PPAR-Alpha Agonist Fenofibrate Combined with Octreotide Acetate in the Treatment of Acute Hyperlipidemia Pancreatitis
por: Bao, Wen, et al.
Publicado: (2021)

Tetrahydropalmatine Prevents High-Fat Diet-Induced Hyperlipidemia in Golden Hamsters (Mesocricetus Auratus)
por: Sun, Caihua, et al.
Publicado: (2018)

Fimasartan Ameliorates Nonalcoholic Fatty Liver Disease through PPARδ Regulation in Hyperlipidemic and Hypertensive Conditions
por: Lee, Yong-Jik, et al.
Publicado: (2017)

A novel camptothecin derivative, ZBH-01, exhibits superior antitumor efficacy than irinotecan by regulating the cell cycle
por: Li, Yongqi, et al.
Publicado: (2023)

A metabolomic study of the PPARδ agonist GW501516 for enhancing running endurance in Kunming mice
por: Chen, Wei, et al.
Publicado: (2015)

Metabolome combined with gut microbiome revealed the lipid-lowering mechanism of Xuezhiping capsule on hyperlipidemic hamster induced by high fat diet
por: Wang, Li, et al.
Publicado: (2023)

Selective Tissue Distribution Mediates Tissue-Dependent PPARγ Activation and Insulin Sensitization by INT131, a Selective PPARγ Modulator
por: Xie, Xinni, et al.
Publicado: (2017)

Melatonin Improves Fatty Liver Syndrome by Inhibiting the Lipogenesis Pathway in Hamsters with High-Fat Diet-Induced Hyperlipidemia
por: Ou, Tzu-Hsuan, et al.
Publicado: (2019)

In Vitro and In Vivo Characterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist
por: He, B. K., et al.
Publicado: (2012)

Comparison of protective effects of hesperetin and pectolinarigenin on high-fat diet-induced hyperlipidemia and hepatic steatosis in Golden Syrian hamsters
por: Shi, Lulu, et al.
Publicado: (2022)

Pan-PPAR Agonist, Bezafibrate, Restores Angiogenesis in Hindlimb Ischemia in Normal and Diabetic Rats
por: Khazaei, M., et al.
Publicado: (2012)

Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis
por: Ruzehaji, Nadira, et al.
Publicado: (2016)

Hypolipidemic effect of XH601 on hamsters of Hyperlipidemia and its potential mechanism
por: Zhao, Meng-Jie, et al.
Publicado: (2017)

Dried mulberry fruit ameliorates cardiovascular and liver histopathological changes in high-fat diet-induced hyperlipidemic mice
por: Chaiwong, Suriya, et al.
Publicado: (2021)

The Potential Mechanism of Wuwei Qingzhuo San against Hyperlipidemia Based on TCM Network Pharmacology and Validation Experiments in Hyperlipidemia Hamster
por: Li, Jianliang, et al.
Publicado: (2020)

The Peroxisome Proliferator-Activated Receptor (PPAR) α Agonist Fenofibrate Suppresses Chemically Induced Lung Alveolar Proliferative Lesions in Male Obese Hyperlipidemic Mice
por: Kuno, Toshiya, et al.
Publicado: (2014)

Medium Chain Fatty Acids Are Selective Peroxisome Proliferator Activated Receptor (PPAR) γ Activators and Pan-PPAR Partial Agonists
por: Liberato, Marcelo Vizoná, et al.
Publicado: (2012)

Anti-Hyperlipidemic Effects and Potential Mechanisms of Action of the Caffeoylquinic Acid-Rich Pandanus tectorius Fruit Extract in Hamsters Fed a High Fat-Diet
por: Zhang, Xiaopo, et al.
Publicado: (2013)

Protective effect of microorganism biotransformation-produced resveratrol on the high fat diet-induced hyperlipidemia, hepatic steatosis and synaptic impairment in hamsters
por: Su, Chun-Hung, et al.
Publicado: (2022)

Ameliorative Effects of Herbal Combinations in Hyperlipidemia
por: Visavadiya, Nishant P., et al.
Publicado: (2011)

Identification of novel multitargeted PPARα/γ/δ pan agonists by core hopping of rosiglitazone
por: Wang, Xue-Jiao, et al.
Publicado: (2014)

The PPAR pan-agonist tetradecylthioacetic acid promotes redistribution of plasma cholesterol towards large HDL
por: Lundåsen, Thomas, et al.
Publicado: (2020)

Acacia nilotica stem bark extract ameliorates obesity, hyperlipidemia, and insulin resistance in a rat model of high fat diet-induced obesity
por: Khalaf, Samar S., et al.
Publicado: (2023)

Hypolipidemic Effects and Safety of Lactobacillus Reuteri 263 in a Hamster Model of Hyperlipidemia
por: Huang, Wen-Ching, et al.
Publicado: (2015)

Hypolipidemic Effect of Tomato Juice in Hamsters in High Cholesterol Diet-Induced Hyperlipidemia
por: Lee, Li-Chen, et al.
Publicado: (2015)

Anthelmintics nitazoxanide protects against experimental hyperlipidemia and hepatic steatosis in hamsters and mice
por: Li, Fengfeng, et al.
Publicado: (2022)

Ginsenoside Rb3 ameliorates podocyte injury under hyperlipidemic conditions via PPARδ- or SIRT6-mediated suppression of inflammation and oxidative stress
por: Oh, Heeseung, et al.
Publicado: (2023)

High-fructose and high-fat diet-induced insulin resistance enhances atherosclerosis in Watanabe heritable hyperlipidemic rabbits
por: Ning, Bo, et al.
Publicado: (2015)

Safety of PPAR Agonists
por: Home, Philip
Publicado: (2011)

Berberine Ameliorates Brain Inflammation in Poloxamer 407-Induced Hyperlipidemic Rats
por: Kim, Mia, et al.
Publicado: (2019)

Curcuma oil ameliorates insulin resistance & associated thrombotic complications in hamster & rat
por: Singh, Vishal, et al.
Publicado: (2015)

Fish Oil and the Pan-PPAR Agonist Tetradecylthioacetic Acid Affect the Amino Acid and Carnitine Metabolism in Rats
por: Bjørndal, Bodil, et al.
Publicado: (2013)

Supplementation with the Traditional Thai Polyherbal Medicine NawaTab Ameliorates Lipid Profiles in High-Fat Diet-Induced Hyperlipidemic Rats
por: Niyomchan, Apichaya, et al.
Publicado: (2022)

PPARγ Agonist and Angiotensin II Receptor Antagonist Ameliorate Renal Tubulointerstitial Fibrosis
por: Han, Jee-Young, et al.
Publicado: (2010)

Deep Sea Water-Dissolved Organic Matter Intake Improves Hyperlipidemia and Inhibits Thrombus Formation and Vascular Inflammation in High-Fat Diet Hamsters
por: Wu, Chia-Chun, et al.
Publicado: (2022)

The Natural PPAR Agonist Linoleic Acid Stimulated Insulin Release in the Rat Pancreas
por: LAI, Min-Chuan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8eslb416ojqnorijac90p1050j